Illumina Chief Executive Jay Flatley, has warned of “unprecedented slowdown in purchasing due to uncertainties in research funding and overall economic conditions.”
Don’t Miss: Apple Cheat Sheet: iPhone Event Recap.
Following is some stock price performance information of these companies:
- Illumina (NASDAQ:ILMN): The shares recently traded at $27.82, down 30.33%, on the day. The shares have traded in a 52-week range of $25.71 to $79.40 and its market capitalization is $3.46 billion. About the company: Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.
(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)
Don’t Miss: Netlix Inks Exclusive Licensing Deal With AMC.